Intervacc AB (publ) (STO:IVACC)
1.144
+0.026 (2.33%)
Aug 1, 2025, 5:29 PM CET
Chimerix Revenue
Intervacc AB had revenue of 4.57M SEK in the quarter ending March 31, 2025, with 91.06% growth. This brings the company's revenue in the last twelve months to 13.97M, up 56.27% year-over-year. In the year 2024, Intervacc AB had annual revenue of 11.79M with 46.84% growth.
Revenue (ttm)
13.97M
Revenue Growth
+56.27%
P/S Ratio
27.92
Revenue / Employee
931.13K
Employees
15
Market Cap
389.89M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11.79M | 3.76M | 46.84% |
Dec 31, 2023 | 8.03M | -4.33M | -35.01% |
Dec 31, 2022 | 12.35M | 3.43M | 38.43% |
Dec 31, 2021 | 8.92M | 1.91M | 27.20% |
Dec 31, 2020 | 7.02M | -7.41M | -51.36% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.31B |
Getinge AB | 35.50B |
Asker Healthcare Group AB | 15.88B |
Medicover AB | 25.22B |
Camurus AB | 2.27B |
Bonesupport Holding AB | 1.06B |
AddLife AB | 10.44B |